Majority of Patients are Supplemental Injection Free after a Single IVT Injection of ADVM-022 in OPTIC
Majority of Patients are Supplemental Injection Free after a Single IVT Injection of ADVM-022 in OPTIC
Format
PNG
Source
Adverum Biotechnologies, Inc.